From 3rd to 5th November 2022, the 2nd Pan-Asia Symposium on Genetics of Brain Disorders brought international experts in neuropsychiatric disorders together to share their latest findings on the genetics of brain disorders and to pave the way for effective therapeutics.
Genetic studies have uncovered changes in particular genes that holds promise to better understanding and treatment of neuropsychiatric disorders. However, the Asian population is under-represented in these studies. Efforts have been made to bridge this gap through the Psychiatric Genomics Consortium (PGC) Schizophrenia Asia working group and the Stanley Global Neuropsychiatric Genetics Initiative. This is a gap that international experts at the symposium have focused on to translate genomic findings into better treatments for the Asian population.
Leading scientists and clinicians from around the world including Prof Liu Jian Jun, Deputy Executive Director and Distinguished Institute Fellow at the Genome Institute of Singapore, discussed significant clinical, genetic and translational aspects of neuropsychiatric disorders during this two-and-a-half-day hybrid conference.
Organised with the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, a global leader in neuropsychiatric research, this symposium brought together leading geneticists, neuroscientists and clinicians from Stanley Center and Singapore to foster future collaboration in neuropsychiatric research in Singapore. The conference hosted by NTU’s Lee Kong Chian School of Medicine was held in Asia to facilitate Asian collaborations in neuropsychiatric research in the region. It was organised by the Genome Institute of Singapore, Institute of Mental Health, NTU’s Lee Kong Chian School of Medicine, NUS’s Yong Loo Lin School of Medicine and the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard.
(Photo credits to LKCMedicine, NTU)